title: Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium.
abstract: There is an urgent need to replace the injection currently used for low molecular weight heparin (LMWH) multidose therapy with a non- or minimally invasive delivery approach. In this study, laser-engineered dissolving microneedle (DMN) arrays fabricated from aqueous blends of 15% w/w poly(methylvinylether-co-maleic anhydride) were used for the first time in active transdermal delivery of the LMWH nadroparin calcium (NC). Importantly, an array loading of 630IU of NC was achieved without compromising the array mechanical strength or drug bioactivity. Application of NC-DMNs to dermatomed human skin (DHS) using the single-step 'poke and release' approach allowed permeation of approximately 10.6% of the total NC load over a 48-h study period. The cumulative amount of NC that permeated DHS at 24h and 48h attained 12.28±4.23IU/cm(2) and 164.84±8.47IU/cm(2), respectively. Skin permeation of NC could be modulated by controlling the DMN array variables, such as MN length and array density as well as application force to meet various clinical requirements including adjustment for body mass and renal function. NC-loaded DMN offers great potential as a relatively low-cost functional delivery system for enhanced transdermal delivery of LMWH and other macromolecules.
authors: Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow, Scotland, UK. yasmine87ag@yahoo.com
authors: Yasmine A
authors: YA
authors: Gomaa
authors: Martin J
authors: MJ
authors: Garland
authors: Fiona
authors: F
authors: McInnes
authors: Labiba K
authors: LK
authors: El-Khordagui
authors: Clive
authors: C
authors: Wilson
authors: Ryan F
authors: RF
authors: Donnelly
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006801:Humans; D007834:Lasers; D046911:Macromolecular Substances / Q000008:administration & dosage; D008845:Microinjections / Q000295:instrumentation* / Q000379:methods*; D017762:Nadroparin / Q000008:administration & dosage* / Q000737:chemistry; D009339:Needles; D010539:Permeability; D012867:Skin / Q000378:metabolism; D012869:Skin Absorption; D013552:Swine
chemical_list: D006495:Heparin, Low-Molecular-Weight; D046911:Macromolecular Substances; D017762:Nadroparin